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1, INTRODUCTION 
A number of recombinant. gene products synthesized 
in EschericCticr co/i precipitate and form insoluble 
cytoplasmic inclusion bodies [l-5], which appear as 
highly refractilc, amorphous granules, not surrounded 
by a membrane [e-8], Inclusion bodies arc thought to 
be formed from in viva protein folding intermediates 
leading to improperly folded, insoluble forms of the 
product (91. Solubilization of the precipitated protein 
usually requires treatment of inclusion bodies with a 
chaotropic agent, such as urea (3,5], and recovery of the 
desired product in a native form is often difficult. 
In this respect, Closrridiwtt rhemtocelluttt en- 
doglucanase D (EGD) stands out as an exception. Fu- 
sion of the celD gene encoding EGD with the /ucZ ’ gene 
of plasmid pUC8 results in levels of EGD expression 
reaching up to 15% of total protein, and about 20-30010 
of the enzyme is found in inclusion bodies, In contrast 
to the majority of inclusion body proteins, EGD ex- 
tracted with urea from the insoluble fraction is highly 
active; furthermore, the protein crystallizes readily, 
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providing additional evidence that it has a highly 
homogeneous and presumably native conformation [8]. 
TO investigate the basis of such a bchaviour, the proper- 
ties of EGD prescnr in inclusion bodies were 
characterized prior to urea solubilization and dialysis. 
2. MATERIALS AND METHODS 
2. I I Pre~watiutr of EGD jrarriattr 
E. co/i JMIOl(pCTGO3) [S] was grown at 37*C in LrtrLl. broth 110) 
containing IO0 &ml cnrbcnicillin, Ccllr from I liter overnight 
cultures were harvested in stationary phase, resuspended in 100 ml SO 
nrhl pomssinm phosphate-12,s mM ritratc buffer, pH 6.3 and 
disrupted in a French pressure cell at 90 MPa (13 000 psi), The broken 
cell suspension was fractionated by ccnfrifugation af 27 000 x gnrrt 
for 20 min into a soluble, cytoplasmic fraction and an insoluble pcller 
containing inclusion bodies. The insoluble fraction was washed rwicc 
by resuspending in 0.15 M NaCl followed by centrifugation for 20 
min at 27 000 x g,,,,,. The washed pcllct was treated with 0.1 M Tris- 
HCI pH 8,s containing 5 M urea [S]. The solubilized protein was 
dialyzed for at least 30 h (4 buffer changes) against 20 mM Tris-HCI, 
pW 7.7, and purified as described previously IS]. 
2.2. Athw-a 
Anti-EGA ant&rum was obtained from rabbits immunized against 
endoglucanasc A (EGA) purified from C. rhenrrocellu~,~ cul~urc 
supernatant [ll]. Anti-EGD antiserum was raised in rabbits immuniz- 
ed against EGD purified from inclusion bodies produced by E. co/i 
JMlOl(pCT603) [S], 
2,3. Wesrenr Olorring 
Samples were heated at 100°C for 5 min in 2% SDS/5% p- 
mercaptoethanol sample buffer, followed by SDS-PAGE [l2]. 
Western blotting was performed according to Towbin et al. [l3]. The 
anti-EGD antiserum was saturated with a crude extract of E. co/i 
TCi(pUCl9) [14] to preznt adsorption to nonqxcific bands. 
2.4. Enzyme assay 
The release of p-nitrophenol from p-nitrophenyl-p-D-cellobioside 
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3. RESULTS 
EGD present in inclusion bodies was analyzed after 
dissolving in SDS-mcrcaptocthanol snmplc buffer [ 12) 
at 100aC (Fig. 1). A major species with an Mr of 68000 
kDa was detected by Western blotting using anti-EGD 
antiserum (lane B), The same species was present after 
treatment of inclusion bodies with 5 M urea (lanes 
C-D). Upon dialysis, however, the 68 kDa form was 
truncated to 65 kDa (lane E), presumably owing to the 
reactivation of a proteasc present in the extract, A 
similar observation was made by Babbit cc al, [17], who 
found that, upon dissolving of aggregates formed in E. 
coli followed by refolding, Torpedo californica crcatine 
kinase and bovine pancreatic trypsin inhibitor are 
degraded by a protease associated with the inclusion 
body fraction. The 65 kDa form, corresponding to the 
species of EGD described previously [8], was purified 
by three precipitation steps using streptomycin sulfate, 
heat treatment and ammonium sulfate [S] (lanes E-H, 
and data not shown). Only the 65 kDa species of EGD 
was detected in the soluble cytoplastnic fraction (lane 
3,2. Conversion of the 68 kDa form into the 65 klOa 
form affects the conserved, reiterated domain 
located at the COOH terminus of EGD. 
The COOH-terminal region encoded by cell con- 
presence of the conserved omain within EGD protein. 
As shown in Fig, 3, the 68 kDa form of EGD (lane b) 
reacted with anti-EGA antibodies. In contrast, no 
cross-reactivity was observed with the 65 kDa form 
(lane c) obtained after dialysis of the tirea extract, nor 
with the 63 kDa form synthesized from a truncated gene 
not encoding the COOH-terminal reiterated region 
(lane a) [IS]. The result confirms previous COOH- 
EGO 
tains two highly homologous segments of 23 amino 
acids each [lg] (Fig. 2), It is strongly ionserved in a 
xylanase and in most endoglucanases of C. ther- 
mocellum whose sequence isknown to date, but it is not 
directly involved in catalytic activity [14,15,19]. 
Signal 
peptide 
Catalytic domain Reiterated, 
consewed 
segments 
Western blotting using antibodies directed against C. 
thermocellum endoglucanase A (EGA) indicated that 
conversion of the 68 kDa polypeptide into the 65 kDa 
form removed at least part of the conserved COOH- 
terminai sequence. EGA has no detectable homology 
with ECiD, except for the reiterated, conserved omain 
present at the CQOH terminus of both proteins. Any 
immunological cross-reactivity of EGD with EGA an- 
tibodies would therefore be expected to be due to the 
GS kDa 
Fig. 2. Domain structure of EGD. The extent of the catalytic domain 
was defined by deletion analysis of cc&? (data not shown). The 
portion of the EGD sequence present in the 63 kDa, in 65 kDa and in 
the 68 kDa forms discussed in the text are shown by horizontal bars. 
Each species resulted from the fusion of cell) in franx with the start 
of iac.2 ', using the Hindlll site present in the polylinker of pUC8 (65 
and 68 kDa forms) [SJ or pUCl9 (63 kDa form) 1151. 
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Fig. 1, Wcrtcrn blotting erdysia nf wriaer Ifiwiorw 0r EGDiralatcd 
from B co/i JhllOl(pCT6O3). ‘IW b1o1 \YaS probed with arrtiESD 
antiscrim~. A, cy!oplasmic supcrnatant; 13, inclusion bodies washed 
twice with 0. IS M NaCI; C, inclusion bodies rerunpcndcd in J M urcn 
before centrifugntion; D-I-1, fractions rrom the purification of ECU 
from inclusion bodies (81; D, 1\1pernatitnt of urea-trcntcd inclusion 
bodies: E, dialyzed urea SQWMI~~; F, supcrnatant after 
streptomycin sulfate rrcatmcnt; C, s\lpcrnatant after Iicat trcatmcnt; 
I-I, :lmn~oiliun~ w-fitr precipitare. IG6 nlJ of cnzymc wcrc loadctl in 
each Innc. 
Fig. 3, Recognition of the 68 kDa form of EGD by antLEGA 
antiserum. Samples were submitted to SDS-PAGE followed by 
Wcslcrn blotting using anti-EGA antiserum. a, 63 kDa EGD (10 +lJ); 
b, 68 kDa EGD (20 j&U); c, 65 kDa ECD (23 $J). 
terminal analysis howing that the 65 kDa species did 
not end at Ile-649, the last residue predicted from the 
nucleotide sequence of c&D [ I$], but at Leu-605 1151, 
which is located at the end of the first repeated segment 
(Fig. 2). 
3.3. &soluble EGD present in inclusion bodies has 
close to full activity. 
EGD present in inclusion bodies could be assayed 
prior to urea solubilization using the low molecular 
weight substrate p-NPC. Control experiments howed 
that the activity was not released in soluble form, but 
remained in the insoluble fraction under the conditions 
of the assay (data not shown). 
As shown in Table I, about 25% of the total activity 
present in the broken cell suspension prior to cen- 
trifugation is accounted for by the insoluble fraction. 
Association of the activity with inclusion bodies and 
not with mm other inrelublc Prarrian (e.g. cell debris) 
wna zuggcsitcd by the enncomitr~nt stppearanec aT inxalrr- 
blc EGD activity nnd af r&=aetilc bodies in rccombi~ 
nnnt ecllz4 (unpublisl~cd data). Furthermore, more than 
90% of’ the activity rcmaincrl in insoluble form al’tcr 
trcatmcnt with 2 M %@I, 20 rnhtl EBTA, or 1% Triten 
X=10(4, or in bulfers with I pfl rwngc of 48 to 8.8, in 
addition, only 12% of the activity was released in sslu- 
blc form in the presence af 2 M urea (data nor shown), 
Neither the urea crcatmcnt, nor the fallowing dialysis 
resulted in loss or increase of activity, This is consistent 
with data showing that purified EGD is fully active in 
the presence of 5 M urra, and that, nt ZO”C, 8 M urea 
does n(31 induce any change detectable by circular 
diehroistn (A. Chaffat te and N. Goldberg, personal 
eornmimicatioi~). 
The specific activity of the c~~zyrlle presetIt in each 
fraction was cnlrularcd after estimating the ainnui~t of 
EGB by Western blotting. Since antibody probing oc- 
curred after the samples had been denatured in SDS at 
lOO”C, the immunoreactivity of the EGD species 
detected was independent of their initial conf’ormation. 
The lowest specific activity wax found for the soluble 
eytoplasmic enzyme (0,9 f 0,2 U/m&. EGD present in 
inclusion bodies prior to solubilization had a specific 
activity of I .J f 0.25 U/mg, close to the activity of the 
purified enzyme (1.6 1 0.4 U/r@. The two minor 
bands detected in Fig, 1, lanes B to H, were not taken 
into account for the calculation of specific activity, 
since, from previous deletion analysis of c&D (data not 
shown), they corresponded to polypeptides too short to 
contain a functional active domain, It is possible that 
other, still smaller EGD fragments were present in 
solubilized inclusion bodies and escaped antibody 
detection. However, the data show that most or all of 
intact size EGD protein present in inclusion bodies (and 
not only a subfraction that would be preferentially 
solubilized in the presence of urea) had nearly normal 
activity. Furthermore, th- e presence cf xtive EGD in 
the insoluble fraction does not seem to be due CO 
passive, non-specific trapping of soluble proteins, since 
the insoluble and the cytoplasmic fraction of 
JM 10 l(pCT603) show quite different electrophoretic 
patterns [8], As pointed out before, the enzyme purified 
Table I 
Distribution of the activity between various EGD fractions isolated 
from E, co/i JMIOl(pCT603) 
Sample Activity (U) Activity yield (‘70) 
Broken cell suspension 130 100 
Cytoptasmic supernatant 100 76 
Washed inclusion bodies 32 25 
Solubitized inclusion bodies 32 as 
Urea dialysate 32 25 - 
Cells from a 1 liter overnight culture (ODhOll = 4.5) were processed 
and the totat activity present in each fraction was assayl:d as described 
in section 2. 
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the! high molecular weiaht cellulslytie eomplcx, UP 
eeIlulorome @I], oP C. fhmw~ocMtrtr. Thus, it might 
act as a ‘sticky’ tail, which wcauld allo cnhanecr inclusiern 
be@ fsrmntion when the prateina arc cxprcextstt in k 
eoti, 
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